{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T12:10:32Z","timestamp":1784549432700,"version":"3.55.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T00:00:00Z","timestamp":1768953600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2024YFC2311100"],"award-info":[{"award-number":["2024YFC2311100"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82302513"],"award-info":[{"award-number":["82302513"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010256","name":"Guangzhou Municipal Science and Technology Project","doi-asserted-by":"publisher","award":["2024A03J0876"],"award-info":[{"award-number":["2024A03J0876"]}],"id":[{"id":"10.13039\/501100010256","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.ijid.2026.108431","type":"journal-article","created":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T16:15:26Z","timestamp":1769184926000},"page":"108431","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Plasma concentrations of IP-10 and MCP-1 as predictors of immunological non-response in people living with HIV receiving antiretroviral therapy"],"prefix":"10.1016","volume":"164","author":[{"given":"Fenqi","family":"Da","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heping","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuemei","family":"Ling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huijun","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingyin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingliang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengyu","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoping","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1757-1411","authenticated-orcid":false,"given":"Haisheng","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5711-8681","authenticated-orcid":false,"given":"Linghua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.ijid.2026.108431_bib0002","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1097\/QAI.0000000000002157","article-title":"Definition of immunological nonresponse to antiretroviral therapy: a systematic review","volume":"82","author":"Rb-Silva","year":"2019","journal-title":"J Acquir Immune Defic Syndr 1999"},{"issue":"4","key":"10.1016\/j.ijid.2026.108431_bib0003","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1002\/JLB.4MR1019-189R","article-title":"Incomplete immune reconstitution in HIV\/AIDS patients on antiretroviral therapy: challenges of immunological non-responders","volume":"107","author":"Yang","year":"2020","journal-title":"J Leukoc Biol"},{"issue":"6","key":"10.1016\/j.ijid.2026.108431_bib0004","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0156099","article-title":"Discordant immune response with antiretroviral therapy in HIV-1: a systematic review of clinical outcomes","volume":"11","author":"Kelly","year":"2016","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ijid.2026.108431_bib0005","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1038\/s41598-022-04866-z","article-title":"Clinical factors and outcomes associated with immune non-response among virally suppressed adults with HIV from Africa and the United States","volume":"12","author":"Noiman","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.ijid.2026.108431_bib0006","article-title":"Recent advances in poor HIV immune reconstitution: what will the future look like?","volume":"14","author":"Zhang","year":"2023","journal-title":"Front Microbiol"},{"issue":"3","key":"10.1016\/j.ijid.2026.108431_bib0007","doi-asserted-by":"crossref","DOI":"10.1002\/jia2.26214","article-title":"Clinical outcomes and risk factors for immune recovery and all-cause mortality in Latin Americans living with HIV with virological success: a retrospective cohort study","volume":"27","author":"Castillo-Rozas","year":"2024","journal-title":"J Int AIDS Soc"},{"key":"10.1016\/j.ijid.2026.108431_bib0008","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1269650","article-title":"Combining CD4 count, CD8 count and CD4\/CD8 ratio to predict risk of mortality among HIV-positive adults after therapy: a group-based multi-trajectory analysis","volume":"14","author":"Ma","year":"2023","journal-title":"Front Immunol"},{"issue":"9","key":"10.1016\/j.ijid.2026.108431_bib0009","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1093\/cid\/ciu038","article-title":"Long-term mortality in HIV-positive individuals virally suppressed for >3 years with incomplete CD4 recovery","volume":"58","author":"Engsig","year":"2014","journal-title":"Clin Infect Dis: Off Publ Infect Dis Soc Am"},{"issue":"5","key":"10.1016\/j.ijid.2026.108431_bib0010","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1097\/QAD.0000000000001730","article-title":"A baseline metabolomic signature is associated with immunological CD4+ T-cell recovery after 36 months of antiretroviral therapy in HIV-infected patients","volume":"32","author":"Rodr\u00edguez-Gallego","year":"2018","journal-title":"AIDS Lond Engl"},{"key":"10.1016\/j.ijid.2026.108431_bib0011","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1186\/s13104-017-2521-0","article-title":"Prevalence and risk factors of poor immune recovery among adult HIV patients attending care and treatment centre in northwestern Tanzania following the use of highly active antiretroviral therapy: a retrospective study","volume":"10","author":"Gunda","year":"2017","journal-title":"BMC Res Notes"},{"issue":"11","key":"10.1016\/j.ijid.2026.108431_bib0012","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.70081","article-title":"Profiles of lymphocyte subtypes in HIV-infected people with different immunologic responses to antiretroviral therapy","volume":"96","author":"Zhao","year":"2024","journal-title":"J Med Virol"},{"issue":"5","key":"10.1016\/j.ijid.2026.108431_bib0013","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1097\/QAD.0b013e32835cb747","article-title":"Risk of clinical progression among patients with immunological nonresponse despite virological suppression after combination antiretroviral treatment","volume":"27","author":"Lapadula","year":"2013","journal-title":"AIDS"},{"issue":"8","key":"10.1016\/j.ijid.2026.108431_bib0014","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0219201","article-title":"Genetic and clinical predictors of CD4 lymphocyte recovery during suppressive antiretroviral therapy: whole exome sequencing and antiretroviral therapy response phenotypes","volume":"14","author":"Greenblatt","year":"2019","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.ijid.2026.108431_bib0015","doi-asserted-by":"crossref","first-page":"15","DOI":"10.4103\/ijstd.ijstd_121_22","article-title":"Immunovirological discordance among people living with human immunodeficiency virus at a center in Western India: a retrospective study","volume":"44","author":"Kacker","year":"2023","journal-title":"Indian J Sex Transm Dis AIDS"},{"key":"10.1016\/j.ijid.2026.108431_bib0016","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s12879-024-09021-9","article-title":"Factors associated with immunological non-response after ART initiation: a retrospective observational cohort study","volume":"24","author":"Zhao","year":"2024","journal-title":"BMC Infect Dis"},{"issue":"2","key":"10.1016\/j.ijid.2026.108431_bib0017","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1097\/QAD.0000000000000815","article-title":"Residual immune activation in combined antiretroviral therapy-treated patients with maximally suppressed viremia","volume":"30","author":"Guihot","year":"2016","journal-title":"AIDS Lond Engl"},{"issue":"4","key":"10.1016\/j.ijid.2026.108431_bib0018","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1093\/infdis\/jiu125","article-title":"Inflammatory cytokines drive CD4+ T-cell cycling and impaired responsiveness to interleukin 7: implications for immune failure in HIV disease","volume":"210","author":"Shive","year":"2014","journal-title":"J Infect Dis"},{"issue":"11","key":"10.1016\/j.ijid.2026.108431_bib0019","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1016\/j.bbamcr.2014.05.014","article-title":"Cytokines and chemokines: at the crossroads of cell signalling and inflammatory disease","volume":"1843","author":"Turner","year":"2014","journal-title":"Biochim Biophys Acta BBA \u2013 Mol Cell Res"},{"issue":"8","key":"10.1016\/j.ijid.2026.108431_bib0020","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1093\/infdis\/jiu238","article-title":"Gut epithelial barrier dysfunction and innate immune activation predict mortality in treated HIV infection","volume":"210","author":"Hunt","year":"2014","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.ijid.2026.108431_bib0021","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/COH.0000000000000242","article-title":"Role of immune activation in progression to AIDS","volume":"11","author":"Utay","year":"2016","journal-title":"Curr Opin HIV AIDS"},{"issue":"06","key":"10.1016\/j.ijid.2026.108431_bib0022","first-page":"481","article-title":"Consensus on diagnosis and management of immunological non-responders in HIV infection (Version 2023)","volume":"36","author":"Li","year":"2023","journal-title":"Infect Dis Inf"},{"key":"10.1016\/j.ijid.2026.108431_bib0023","doi-asserted-by":"crossref","DOI":"10.3389\/fviro.2022.822153","article-title":"CD4+ T lymphocyte recovery in the modern antiretroviral therapy era: toward a new threshold for defining immunological non-responders","volume":"2","author":"Taramasso","year":"2023","journal-title":"Front Virol"},{"issue":"3","key":"10.1016\/j.ijid.2026.108431_bib0024","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1086\/510746","article-title":"CD4+ Cell count 6 years after commencement of highly active antiretroviral therapy in persons with sustained virologic suppression","volume":"44","author":"Moore","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"7","key":"10.1016\/j.ijid.2026.108431_bib0025","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1097\/QAD.0b013e3282f7cb76","article-title":"CD4+ count and risk of non-AIDS diseases following initial treatment for HIV infection","volume":"22","author":"Baker","year":"2008","journal-title":"AIDS Lond Engl"},{"issue":"6","key":"10.1016\/j.ijid.2026.108431_bib0026","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1084\/jem.177.6.1809","article-title":"Recombinant human interferon-inducible protein 10 is a chemoattractant for human monocytes and T lymphocytes and promotes T cell adhesion to endothelial cells","volume":"177","author":"Taub","year":"1993","journal-title":"J Exp Med"},{"issue":"7","key":"10.1016\/j.ijid.2026.108431_bib0027","doi-asserted-by":"crossref","first-page":"3195","DOI":"10.4049\/jimmunol.168.7.3195","article-title":"IFN-\u03b3-inducible protein 10 (IP-10; CXCL10)-deficient mice reveal a role for IP-10 in effector T cell generation and Trafficking1","volume":"168","author":"Dufour","year":"2002","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.ijid.2026.108431_bib0028","first-page":"138","article-title":"Plasma IP-10 is increased in immunological NonResponders and associated with activated regulatory T cells and persisting low CD4 counts","volume":"73","author":"B","year":"2016","journal-title":"J Acquir Immune Defic Syndr 1999"},{"issue":"7","key":"10.1016\/j.ijid.2026.108431_bib0029","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1097\/QAD.0000000000002173","article-title":"Activated dendritic cells and monocytes in HIV immunological nonresponders: HIV-induced interferon-inducible protein-10 correlates with low future CD4+ recovery","volume":"33","author":"Stiksrud","year":"2019","journal-title":"AIDS Lond Engl"},{"issue":"6","key":"10.1016\/j.ijid.2026.108431_bib0030","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1089\/jir.2008.0027","article-title":"Monocyte chemoattractant protein-1 (MCP-1): an overview","volume":"29","author":"Deshmane","year":"2009","journal-title":"J Interferon Cytokine Res"},{"issue":"12","key":"10.1016\/j.ijid.2026.108431_bib0031","doi-asserted-by":"crossref","first-page":"3412","DOI":"10.1002\/eji.201141676","article-title":"CCL2: a potential prognostic marker and target of anti-inflammatory strategy in HIV\/AIDS pathogenesis","volume":"41","author":"Ansari","year":"2011","journal-title":"Eur J Immunol"},{"issue":"1","key":"10.1016\/j.ijid.2026.108431_bib0032","doi-asserted-by":"crossref","first-page":"76","DOI":"10.2174\/138945011701151217110917","article-title":"The CCL2\/CCR2 axis in the pathogenesis of HIV-1 infection: a new cellular target for therapy?","volume":"17","author":"Angela Covino","year":"2015","journal-title":"Curr Drug Targets"},{"key":"10.1016\/j.ijid.2026.108431_bib0033","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.103077","article-title":"High circulating SDF-1and MCP-1 levels and genetic variations in CXCL12, CCL2 and CCR5: prognostic signature of immune recovery status in treated HIV-positive patients","volume":"62","author":"Yeregui","year":"2020","journal-title":"EBioMedicine"},{"key":"10.1016\/j.ijid.2026.108431_bib0034","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2025.111951","article-title":"Insights on the role of the chemokine CCL8 in pathology","volume":"134","author":"Chavez","year":"2025","journal-title":"Cell Signal"},{"issue":"8","key":"10.1016\/j.ijid.2026.108431_bib0035","doi-asserted-by":"crossref","first-page":"4289","DOI":"10.1074\/jbc.273.8.4289","article-title":"Monocyte chemotactic protein-2 activates CCR5 and blocks CD4\/CCR5-mediated HIV-1 entry\/replication","volume":"273","author":"Gong","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ijid.2026.108431_bib0036","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.virol.2014.06.008","article-title":"HIV replication in conjunction with granzyme B production by CCR5+ memory CD4 T cells: implications for bystander cell and tissue pathologies","volume":"462\u20133","author":"Couturier","year":"2014","journal-title":"Virology"},{"key":"10.1016\/j.ijid.2026.108431_bib0037","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1392535","article-title":"Reassessing granzyme B: unveiling perforin-independent versatility in immune responses and therapeutic potentials","volume":"15","author":"Thompson","year":"2024","journal-title":"Front Immunol"},{"issue":"6","key":"10.1016\/j.ijid.2026.108431_bib0038","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1189\/jlb.3A0414-232RR","article-title":"High IP-10 levels decrease T cell function in HIV-1-infected individuals on ART","volume":"96","author":"Ramirez","year":"2014","journal-title":"J Leukoc Biol"},{"issue":"10","key":"10.1016\/j.ijid.2026.108431_bib0039","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1086\/374786","article-title":"T cell activation is associated with lower CD4+ T cell gains in human immunodeficiency virus-infected patients with sustained viral suppression during antiretroviral therapy","volume":"187","author":"Hunt","year":"2003","journal-title":"J Infect Dis"},{"issue":"5","key":"10.1016\/j.ijid.2026.108431_bib0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004078","article-title":"HIV-infected individuals with low CD4\/CD8 ratio despite effective antiretroviral therapy exhibit altered T cell subsets, heightened CD8+ T cell activation, and increased risk of non-AIDS morbidity and mortality","volume":"10","author":"Serrano-Villar","year":"2014","journal-title":"PLoS Pathog"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971226000664?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971226000664?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T11:56:40Z","timestamp":1784548600000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971226000664"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":39,"alternative-id":["S1201971226000664"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2026.108431","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Plasma concentrations of IP-10 and MCP-1 as predictors of immunological non-response in people living with HIV receiving antiretroviral therapy","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2026.108431","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}],"article-number":"108431"}}